Literature DB >> 35710508

Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2.

Anita Verma1, Mahtab Moayeri2, Christopher P Mocca1, Danielle O'Mard2, Qian Ma2, Stephen H Leppla2, Drusilla L Burns1.   

Abstract

Anthrax protective antigen (PA), the receptor-binding component of anthrax toxin, elicits toxin-neutralizing antibodies which provide protection against anthrax disease. PA binds to two mammalian receptors, capillary morphogenesis protein-2 (CMG2) and tumor endothelial marker-8 (TEM8). We previously observed that binding of PA to its receptors plays a role in eliciting a strong toxin-neutralizing antibody response. In this study, we examined the roles that individual receptors play in mediating the toxin-neutralizing antibody response. Mice immunized with PA that binds preferentially to CMG2 elicited a toxin-neutralizing antibody response similar to that elicited by wild-type PA, whereas the antibody response elicited by PA that binds preferentially to TEM8 was significantly lower. Also, the toxin-neutralizing antibody response elicited by wild-type PA in CMG2-null mice was found to be significantly lower than that induced in CMG2-sufficient mice, further supporting a predominant role for the CMG2 receptor in mediating a protective antibody response to PA. Published by Elsevier Ltd.

Entities:  

Keywords:  Anthrax protective antigen; CMG2 receptor; CMG2-null mice; Toxin-neutralizing antibodies

Mesh:

Substances:

Year:  2022        PMID: 35710508      PMCID: PMC9308747          DOI: 10.1016/j.vaccine.2022.06.023

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   4.169


  15 in total

Review 1.  Anthrax toxin: receptor binding, internalization, pore formation, and translocation.

Authors:  John A T Young; R John Collier
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

2.  Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis.

Authors:  Boris Ionin; Robert J Hopkins; Brett Pleune; Gloria S Sivko; Frances M Reid; Kristin H Clement; Thomas L Rudge; Gregory V Stark; Alison Innes; Suha Sari; Tina Guina; Cris Howard; Jeffrey Smith; M Lisa Swoboda; Ekaterina Vert-Wong; Virginia Johnson; Gary S Nabors; Mario H Skiadopoulos
Journal:  Clin Vaccine Immunol       Date:  2013-05-08

3.  Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant.

Authors:  Leslie Wagner; Anita Verma; Bruce D Meade; Karine Reiter; David L Narum; Rebecca A Brady; Stephen F Little; Drusilla L Burns
Journal:  Clin Vaccine Immunol       Date:  2012-07-18

4.  Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques.

Authors:  Ligong Chen; Jarad M Schiffer; Shannon Dalton; Carol L Sabourin; Nancy A Niemuth; Brian D Plikaytis; Conrad P Quinn
Journal:  Clin Vaccine Immunol       Date:  2014-09-03

5.  In vitro correlate of immunity in a rabbit model of inhalational anthrax.

Authors:  M L Pitt; S F Little; B E Ivins; P Fellows; J Barth; J Hewetson; P Gibbs; M Dertzbaugh; A M Friedlander
Journal:  Vaccine       Date:  2001-09-14       Impact factor: 3.641

6.  Both CD4+ and CD8+ T cells respond to antigens fused to anthrax lethal toxin.

Authors:  Christine A Shaw; Michael N Starnbach
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

7.  Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.

Authors:  Shihui Liu; Devorah Crown; Sharmina Miller-Randolph; Mahtab Moayeri; Hailun Wang; Haijing Hu; Thomas Morley; Stephen H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-15       Impact factor: 11.205

Review 8.  Anthrax toxin.

Authors:  R John Collier; John A T Young
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

9.  Role of the Antigen Capture Pathway in the Induction of a Neutralizing Antibody Response to Anthrax Protective Antigen.

Authors:  Anita Verma; Miriam M Ngundi; Gregory A Price; Kazuyo Takeda; James Yu; Drusilla L Burns
Journal:  mBio       Date:  2018-02-27       Impact factor: 7.867

10.  Binding of the von Willebrand Factor A Domain of Capillary Morphogenesis Protein 2 to Anthrax Protective Antigen Vaccine Reduces Immunogenicity in Mice.

Authors:  Fabiana Freire Mendes de Oliveira; Sireesha Mamillapalli; Srinivas Gonti; Robert N Brey; Han Li; Jarad Schiffer; Arturo Casadevall; James G Bann
Journal:  mSphere       Date:  2020-01-15       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.